News & Updates
Filter by Specialty:
Concurrent DOAC, tamoxifen use poses no elevated bleeding risk
In breast cancer patients receiving direct oral anticoagulants (DOACs), tamoxifen is safe to use and does not increase the risk of haemorrhage as compared with concurrent use of an aromatase inhibitor (AI), a study has found.
Concurrent DOAC, tamoxifen use poses no elevated bleeding risk
05 Jul 2022
Deep submucosal invasion not independently linked to metastasis in colorectal cancer
In the absence of other histological risk factors, deep submucosal invasion is not strongly predictive of lymph node metastasis in patients with T1 colorectal cancer, reports a recent meta-analysis.
Deep submucosal invasion not independently linked to metastasis in colorectal cancer
04 Jul 2022
Physiotherapy improves neuropathic pain biomarker profile
Physiotherapeutic interventions, like exercise therapy and electro-acupuncture, appear to be effective at reducing the expression of neuropathic pain biomarkers, reveals a new systematic review.
Physiotherapy improves neuropathic pain biomarker profile
04 Jul 2022
Healthy plant-based diet may reduce breast cancer risk
Adherence to a healthy plant-based diet was tied to a reduced risk of breast cancer, according to a French study presented at Nutrition 2022. In contrast, an unhealthy plant-based diet may be tied to increased breast cancer risk.
Healthy plant-based diet may reduce breast cancer risk
04 Jul 2022
TNFi use carries only modest increase in psoriasis risk
The use of tumour necrosis factor-α inhibitor (TNFi) for inflammatory bowel disease (IBD) or rheumatoid arthritis (RA) raises the risk of developing psoriasis by twofold as compared with conventional therapy, although the absolute risk remains modest, as reported in a study.
